WirTek A/S
Wirtek announces our new 5-year growth strategy with an expected average annual growth rate of 30%.
- Wirtek’s long-term goal is an annual revenue of DKK 100 million with pre-tax earnings of DKK 10 million before the end of 2025.
 - Wirtek expects to grow profitably with an annual EBITDA margin of at least 6% during the entire 5-year strategic period.
 
Wirtek has defined four strategic tracks in order to reach the financial goals :
- Accelerated profitable growth through a combination of organic growth and acquisitions.
 - International sales expansion with focus on select geographical markets in North-Western Europe.
 - Scalable and sustainable sourcing in nearshore locations with right combination of skills, capacity, culture, stability, and cost.
 - A continued positioning of Wirtek as "Best-in-class workplace".
 
The detailed description of the strategy is attached to this announcement.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Atlantica Sustainable Infrastructure LTD4.11.2025 00:20:41 CET | Press release
Atlantica Announces Pricing of Additional $285 Million of 6.375% Green Senior Notes due 2032
Colliers International Group Inc3.11.2025 23:00:00 CET | Press release
Colliers adds top-tier Australian engineering firm
DBV Technologies S.A.3.11.2025 22:30:00 CET | Press release
DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
DBV Technologies S.A.3.11.2025 22:25:00 CET | Press release
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
Galapagos NV3.11.2025 22:01:00 CET | Press release
Galapagos to Present New Data from Cell Therapy Program at ASH 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
